Senior insider sale
ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$3.14M
124.69K shares
What this filing means
NEUPERT PETER M plans to sell 124.69K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $3.14M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001950047-26-008277
Director
Since Jun 2019
124.69K
Shares to sell
$3.14M
Approx. market value
124.69K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
Stock Option Exercise
Cash
8/17/2026
15KRestricted Stock
Not Applicable
3/4/2026
15.39KExercised Shares
Cash
3/10/2025
40KRestricted Stock
Not Applicable
3/4/2025
31.33KRestricted Stock
Not Applicable
3/4/2024
14.78KRestricted Stock
Not Applicable
1/26/2023
6.69KRestricted Stock
Not Applicable
2/14/2022
1.50KTotal acquired124.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Stock Option Exercise Cash | 15K | — |
3/4/2026 | Restricted Stock Not Applicable | 15.39K | — |
3/10/2025 | Exercised Shares Cash | 40K | — |
3/4/2025 | Restricted Stock Not Applicable | 31.33K | — |
3/4/2024 | Restricted Stock Not Applicable | 14.78K | — |
1/26/2023 | Restricted Stock Not Applicable | 6.69K | — |
2/14/2022 | Restricted Stock Not Applicable | 1.50K | — |
| Total | 124.69K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
124.69K
Market value
$3.14M
8/17/2026
Total
Units
124.69K
Value
$3.14M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 124.69K | $3.14M | NASDAQ | Planned |
| Total | 124.69K | $3.14M | ||